Latham Guides Genstar In $400M Pharma Research Co. Buy

Law360, New York (April 10, 2012, 2:28 PM EDT) -- San Francisco-based private equity firm Genstar Capital LLC plans to buy up eResearchTechnology Inc., a research service provider for bio-pharmaceutical companies, for about $400 million, the Philadelphia-based data cruncher said Tuesday.

Having inked a definitive agreement and gotten support from the company's board of directors, Genstar plans to purchase the global research firm for $8 per share in an all-cash deal, according to ERT. The purchase price represents a premium of about 38 percent over the company's average closing price for the last three months and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.